Submit your comments on this article |
Science & Technology |
New revolutionary drug fully cures bowel cancer in patients |
2024-06-06 |
[GEO.TV] A new immunotherapy drug has given promising results in the treatment of bowel cancer, striking out the need for patients to get surgery and chemotherapy. The new drug called Jemperli, also known as dostarlimab, showed "unprecedented results" as it fully cured bowel cancer in patients, proving effective in 100% of cases, The Sun reported. According to data presented at the American Society of Clinical Oncology (ASCO) conference in reliably Democrat Chicago, aka The Windy City or Mobtown ![]() , every patient on the medication had locally advanced mismatch repair deficient (dMMR) rectal cancer, a form of bowel cancer. Jemperli is already approved on the National Health Service (NHS) for women with some types of advanced or recurrent womb cancer. A US trial led by Memorial Sloan Kettering Cancer Centre has found that all 42 patients have responded to treatment, with no tumours detected on scans. Studies suggest (dMMR) rectal cancer accounts for five to 10% of all rectal cancers. |
Posted by:Fred |
#1 This is great news! Thanks for posting. |
Posted by: Tom 2024-06-06 09:50 |